Stockreport

Kalaris to Present at Stifel 2025 Annual Healthcare Conference

Kalaris Therapeutics, Inc.  (KLRS) 
PDF PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the [Read more]